Cargando…
Eradication of CD48-positive tumors by selectively enhanced YTS cells harnessing the lncRNA NeST
Natural killer (NK) cells are currently used in clinical trials to treat tumors. However, such therapies still suffer from problems such as donor variability, reproducibility, and more, which prevent a wider use of NK cells therapeutics. Here we show a potential immunotherapy combining NK cell-media...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440710/ https://www.ncbi.nlm.nih.gov/pubmed/37609636 http://dx.doi.org/10.1016/j.isci.2023.107284 |